Clinical Trials Logo
  1. Home
  2. Deep Vein Thrombosis
  3. NCT04252651
  4. Details
NCT04252651 Clinical Trial

Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients

Deep Vein Thrombosis Clinical Trial

Official title:
Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04252651
Other study ID # JMSRF-CYT-P04
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 2, 2019
Est. completion date December 2022

Study information
Verified date August 2021
Source Joseph M. Still Research Foundation, Inc.
Contact Joan Wilson
Phone 7063642966
Email joan.wilson@jmsresearchfoundation.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will involve blood draws to test for specific cytokines. The study goal is to gain a better understanding of the role of inflammatory response in the development of specific complications in burn and TENS patients.

Recruitment information / eligibility
Status Recruiting
Enrollment 65
Est. completion date December 2022
Est. primary completion date October 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - is =18 years of age - has been admitted to the Joseph M. Still Burn Center at Doctors Hospital Augusta with a burn diagnosis, or TENS OR SJS diagnosis (confirmed or non-confirmed), with an expected length of stay to be at least 7 days - the subject or their legally authorized representative is able to provide informed consent - has a negative urine or serum pregnancy test at screening (if female and has potential for pregnancy) Exclusion Criteria: - is moribund, or in the opinion of the investigator is not expected to survive - has sustained an electrical burn

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Blood Draw
This study will involve blood draws to test for specific cytokines

Locations
Country Name City State
United States Joseph M. Still Burn Center at Doctors Hospital Augusta Georgia

Sponsors (1)
Lead Sponsor Collaborator
Joseph M. Still Research Foundation, Inc.

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Cytokine Response that develops into complications The number of burn and TENS patients that develop subsequent medical complications up to one year
See also
  Status Clinical Trial Phase
Recruiting NCT05003843 - BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis N/A
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Withdrawn NCT04136561 - Novel Strategy to Encourage Early Removal of Central Venous Catheters N/A
Completed NCT03420625 - Blood Flow Stimulation in the Lower Limbs by Application of Different External Devices N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02555111 - Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. Phase 3
Completed NCT01975090 - The SENTRY Clinical Study N/A
Terminated NCT02469376 - Evaluation of a New Imagingtechnologie for Thrombosis Phase 1
Completed NCT02037607 - Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures N/A
Not yet recruiting NCT01357941 - Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) N/A
Completed NCT00773448 - Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism N/A
Completed NCT00720915 - D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months N/A
Completed NCT00771303 - Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
Completed NCT00244725 - Odiparcil For The Prevention Of Venous Thromboembolism Phase 2
Completed NCT00264277 - D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism Phase 4
Completed NCT00365950 - 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE Phase 4
Completed NCT00182403 - Fixed Dose Heparin Study Phase 3
Completed NCT03682419 - Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL) N/A
Not yet recruiting NCT04981327 - The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis Phase 3
Recruiting NCT03240120 - A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism Phase 3